GulfNews FDA stops sale of weight loss drug in Upper Southampton Montgomery Newspapers The Food and Drug Administration has forced an Upper Southampton based Internet web seller to stop selling a weight loss capsule because it ... Weight-loss pill recalled Gulf Today Herbal weight loss pill banned Biomed Middle East all 5 news articles?? Read more »
Recall of Weight Loss Pills, Contains an Undeclared Drug, Nationwide – Kansas City infoZine
Recall of Weight Loss Pills, Contains an Undeclared Drug, Nationwide Kansas City infoZine Southampton, PA - infoZine - Shaping Beauty, Inc. has been informed by the Food and Drug Administration (FDA) that a weight loss dietary supplement sold and ... Read more »
FDA Says No to Weight-Loss Combo Drug – ABC News
FDA Says No to Weight-Loss Combo Drug ABC News A pill combining bupropion and naltrexone for weight loss (Contrave) won't receive the FDA's approval until its ... Weight loss drug Contrave banned by FDA, Orexigen gets humiliating drubbing Khabrein FDA declines to approve Orexigen diet drug TMCnet FDA Issues Complete Response to New Drug Application for Contrave® for the ... PR-USA.net (press release) UAB News ?- FDA news (subscription) all 16 news articles?? Read more »
Weight loss drug Contrave banned in US besides sexual enhancement drugs – Khabrein
Weight loss drug Contrave banned in US besides sexual enhancement drugs Khabrein Weight loss drug Contrave banned in US besides sexual enhancement drugs. The drugs with side effects must not be allowed in the market The Food and Drug .. Read more »
Shaping Beauty Weight Loss Pills Recalled Nationwide – Lawyers and Settlements
Shaping Beauty Weight Loss Pills Recalled Nationwide Lawyers and Settlements Washington, DC: Shaping Beauty, Inc. Read more »
USA: Weight Loss Therapy Rejected By FDA, Again – Culture Clash Daily
USA: Weight Loss Therapy Rejected By FDA, Again Culture Clash Daily Yet last month Canada recalled a weight loss drug, that had been already on the market, for fear that consumers were at greater risk of strokes, ... Read more »
Vivus Inc (NASDAQ: VVUS) Still in the Game After FDA’s – OTCEquity.com
Los Angeles Times Vivus Inc (NASDAQ: VVUS) Still in the Game After FDA's OTCEquity.com The three-way race to get the first FDA approved weight-loss drug on the market in more than a decade has caused many investors to shed a few pounds of ... Read more »
FDA rejects weight loss drug Contrave – Boston Globe
Los Angeles Times FDA rejects weight loss drug Contrave Boston Globe Company studies of the drug, a combination of an antidepressant and an antiaddiction drug to curb appetite, showed it had modest weight-loss benefits. .. Read more »
FDA won’t approve weight-loss drug Contrave – Kansas City Star
Los Angeles Times FDA won't approve weight-loss drug Contrave Kansas City Star Last October, the FDA rejected the proposed weight-loss drug Qnexa because of concerns about heart problems and birth defects. That same month, the agency ... FDA Won't Approve Weight Loss Drug Contrave WebMD Weight Loss Drug Contrave Rejected by FDA HealthNews FDA rejects Orexigen's weight-loss drug Contrave AFP MyHealthNewsDaily ?- Daily Health Report ?- Los Angeles Times all 496 news articles?? Read more »
FDA Won’t Approve Weight Loss Drug Contrave
The FDA has for now decided not to approve the weight loss drug Contrave. Read more »
